1 year return (CAGR)
-
Evommune, Inc. Exchange (NYSE, USD)
EVMN
9.45
-0.20 (-2.07%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
342.96M
Price/Sales
34.30
Ent value
307.29M
Price/Book
1.24
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.70 |
| Daily high | 9.70 |
| Daily low | 9.35 |
| Daily Volume | 603K |
| All-time high | 31.57 |
| 1y analyst estimate | 27.63 |
| Beta | - |
| EPS (TTM) | -2.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| EVMN | S&P500 | |
| Current price drop from All-time high | -70.07% | -0.56% |
| Highest price drop | -70.32% | -56.47% |
| Date of highest drop | 17 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -29.89% | -10.68% |
| Avg time to new high | 17 days | 12 days |
| Max time to new high | 151 days | 1805 days |
News
